Executive Committee: Bright Minds Biosciences Inc.

Manager
Positions heldSince
Ian McDonald

Ian McDonald

38 year

Chief Executive Officer 04/06/2020
Founder 30/05/2019
President 30/05/2019
Ryan Cheung

Ryan Cheung

47 year

Director of Finance/CFO 28/05/2020
Corporate Secretary -
Jan Pedersen

Jan Pedersen

61 year

Chief Tech/Sci/R&D Officer 26/06/2022
Alex Vasilkevich

Alex Vasilkevich

Chief Operating Officer 31/05/2024
Public Communications Contact -
Stephen D. Collins

Stephen D. Collins

Chief Tech/Sci/R&D Officer 06/01/2025

Composition of the Board of Directors: Bright Minds Biosciences Inc.

Director
CommitteesSince
David Weiner

David Weiner

61 year

Audit Committee 16/02/2023
Compensation Committee 16/02/2023
Governance Committee 16/02/2023
Nominating Committee
Ian McDonald

Ian McDonald

38 year

Audit Committee
Compensation Committee
Governance Committee
Nominating Committee
Nils Bottler

Nils Bottler

38 year

Audit Committee Chair 28/09/2020
Compensation Committee Chair 28/09/2020
Governance Committee Chair 28/09/2020
Nominating Committee Chair 28/09/2020
Jeremy Fryzuk

Jeremy Fryzuk

40 year

Audit Committee 28/09/2020
Compensation Committee 28/09/2020
Governance Committee 28/09/2020
Nominating Committee 28/09/2020
Jan Pedersen

Jan Pedersen

61 year

Director/Board Member 31/03/2022

Former Officers and Directors: Bright Minds Biosciences Inc.

Insider
Positions held
SinceUntil
Mark Smith
Mark Smith
Chief Tech/Sci/R&D Officer 30/11/2022 06/01/2025
Douglas Williamson
Douglas Williamson
Director/Board Member 06/09/2022 08/01/2023
Independent Dir/Board Member 06/09/2022 08/01/2023
Revati Shreeniwas
Revati Shreeniwas
Chief Tech/Sci/R&D Officer 04/06/2020 30/11/2022
Alan Kozikowski
Alan Kozikowski
Director/Board Member 30/05/2019 06/09/2022
Chief Tech/Sci/R&D Officer 28/10/2020 26/06/2022
Founder 30/05/2019 06/09/2022
Emer Leahy
Emer Leahy
Director/Board Member 09/06/2021 24/04/2022
Independent Dir/Board Member 09/06/2021 24/04/2022
Thomas Lategan
Thomas Lategan
General Counsel 13/06/2021 -
Gideon Shapiro
Gideon Shapiro
Corporate Officer/Principal 28/09/2020 -

Age distribution of managers

Parity Men Women

Male8
Female0

Of which Executive Committee

Male5
Female0

Of which Directors

Male5
Female0
Logo Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc. is a biotechnology company, which is engaged in developing treatments for patients with neurological and psychiatric disorders. The Company is focused on developing highly selective 5-HT2 agonists for the treatment of drug-resistant epilepsy, depression, and other central nervous system (CNS) disorders. Its Serotonin (5-HT) is a neurotransmitter in the brain and modulates many biological functions. Dysfunction of serotonin receptors, transporters, and associated neurocircuits is fundamental to many diseases including epilepsies and neuro psychiatric. Its pipeline includes BMB-101, BMB-xxx, BMB-201, and BMB-202. The Company has a portfolio of patented, selective serotonin (5-HT2C, 5-HT2A and 5-HT2C/A-receptor subtypes) agonists that were identified by using high-throughput screening methods in combination with advanced molecular modeling techniques to interrogate the interaction between the drug and its targeted receptors to increase downstream signaling.
Employees
26
More about the company